Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 7 | Showing Results 1 - 5 of 33

AM0010-201: A Randomized Phase 2 Trial of AM0010 in Combination with Pembrolizumab vs. Pembrolizumab Alone as First-line Therapy in Patients with Metastatic Non-Small Cell Lung Cancer whose Tumors Have High PD-L1 Expression

This Study provides first-line treatment to patients diagnosed with Non-Small Cell Lung Cancer. There are two arms patients can be randomized to:...

Isaac Tafur, M.D.
  • SJH Texas

SJH 14-096-Alliance A151216- A Genetic Testing for patients with Resectable or resected lung cancer. Adjuvant Lung Cancer enrichment maker identification and sequencing trial (ALCHEMIST )

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by...

Isaac Tafur, M.D.
  • Covenant Medical Center
  • SJH Texas

SJH 14-102-E4512: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

This randomized phase III trial studies how well crizotinib works and compares it to placebo in treating patients with stage IB-IIIA non-small cell...

Isaac Tafur, M.D.
  • Covenant Medical Center
  • SJH Texas

SJH 14-093-Alliance A081105- A randomized double blind placebo controlled study of Erlotinib or placebo in patients with completely resected epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) (Alchemist 2)

This randomized phase III trial studies how well erlotinib hydrochloride compared to observation works in treating patients with stage IB-IIIA...

Isaac Tafur, M.D.
  • Covenant Medical Center
  • SJH Texas

AM0010-202: A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1 (Cypress2)

This study will compare the efficacy of AM0010 in combination with nivolumab (Arm 1) vs. nivolumab alone (Arm 2) in patients with NSCLC. Efficacy...

Isaac Tafur, M.D.
  • SJH Texas
« Previous 12345 Next »
Viewing Page 1 of 7 | Showing Results 1 - 5 of 33